Indole compounds for use in treating inflammation and cancer

Provided herein are compounds, comprising Formula (I) or Formula (II), and their pharmaceutically acceptable salts. Also provided are pharmaceutical compositions comprising a pharmaceutically acceptable excipient and at least one compound of Formula (I) and (II), singly or in combination with other pharmaceutically active ingredients, such as anti-inflammatory agents or anticancer agents.

ABSTRACT

Provided herein are compounds, comprising Formula (I) or Formula (II), and their pharmaceutically acceptable salts. Also provided are pharmaceutical compositions comprising a pharmaceutically acceptable excipient and at least one compound of Formula (I) and (II), singly or in combination with other pharmaceutically active ingredients, such as anti-inflammatory agents or anticancer agents. These compounds and pharmaceutical compositions are useful for treating inflammation or an inflammation related disorder in a subject via administration to the subject. These compounds and pharmaceutical compositions are also useful for inhibiting COX-2, for treating cancer, for reducing the size of a neoplasm, and for inhibiting tubulin polymerization in a cell.

CLAIMS

1. A compound comprising Formula (I) or a pharmaceutically acceptable salt thereof: wherein: R1 is chosen from hydrogen, halogen, hydrocarbyl, and substituted hydrocarbyl; R2 is chosen from hydrocarbyl and substituted hydrocarbyl; X1 is chosen from hydrocarbyl, substituted hydrocarbyl, nitrogen, oxygen, and sulfur; X2 is chosen from hydrocarbyl, substituted hydrocarbyl, nitrogen, oxygen, and sulfur; and n is an integer from 0 to 10.

PATENT INFORMATION


Interested in this Technology?

The technologies listed here are available for licensing or for developmental partnership.
Please contact us if you have any questions, or if you would like further information on these or other upcoming BioVentures technologies.

Contact